Unknown

Dataset Information

0

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19.

ABSTRACT:

SUBMITTER: Agusti A 

PROVIDER: S-EPMC8040539 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
| S-EPMC8040526 | biostudies-literature
Unknown Prognostic Accuracy of Early Warning Scores for Clinical Deterioration in Patients With COVID-19.
| S-EPMC7882600 | biostudies-literature
Unknown [Multicenter validation of Early Warning Scores for detection of clinical deterioration in COVID-19 hospitalized patients].
| S-EPMC8629741 | biostudies-literature
Unknown RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19.
| S-EPMC8225459 | biostudies-literature
Unknown Budesonide: A promising candidate therapeutic for early COVID-19.
| S-EPMC8327609 | biostudies-literature
Unknown Clinical Efficacy of Corticosteroids in the Early Stages of Deterioration in COVID-19 Pneumonia.
| S-EPMC8285565 | biostudies-literature
Unknown Exposure-Response and Clinical Outcome Modeling of Inhaled Budesonide/Formoterol Combination in Asthma Patients.
| S-EPMC7238265 | biostudies-literature
Unknown Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.
| S-EPMC7290833 | biostudies-literature
Unknown PEP-CoV protocol: a PEP flute-self-care randomised controlled trial to prevent respiratory deterioration and hospitalisation in early COVID-19.
| S-EPMC8249175 | biostudies-literature
Unknown Predictors of clinical deterioration in non-severe patients with COVID-19: a retrospective cohort study.
| S-EPMC7876670 | biostudies-literature